Gene · 708
NIH grants1,264
NIH grants whose papers are about the gene, through NIH's grant-paper links.
641 to 660 of 1,264
Download this page as JSON| Grant | Title | C1QBP papers | Newest fiscal year |
|---|---|---|---|
| U54HD060848 | Biomarkers for Therapy of FSHD (U54) | 3 | 2017 |
| K01DK098285 | Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosis | 2 | 2017 |
| R01MH067880 | Quantitative Proteome Analysis of Brain Development | 2 | 2017 |
| ZIAAI001000 | Malaria Pathogenesis and Human Immunity | 2 | 2017 |
| F31AI114240 | Emerging roles for interferon inducible protein IFIX in innate immune response | 1 | 2017 |
| F32DK108493 | Characterization of TR2 and TR4 homodimer and heterodimer transcriptional mechanisms during erythropoiesis. | 1 | 2017 |
| F32GM112495 | Structural characterization of protein complexes involved in embryogenesis. | 1 | 2017 |
| I01BX002386 | Endostatin-derived Short Peptides in Corneal Transplantation | 1 | 2017 |
| K01DK095067 | A critical role of TAM receptors in autoimmune nephritis | 1 | 2017 |
| K12GM074869 | Training in Education and Critical Research Skills | 1 | 2017 |
| K99CA207865 | Dissect regulation of RNA translation in human cancers | 1 | 2017 |
| K99CA208028 | Investigating the role of RBM10-regulated alternative splicing in lung tumorigenesis | 1 | 2017 |
| K99HL133372 | Regulation of Mitochondrial Inner Membrane Organization | 1 | 2017 |
| P01CA067166 | Tumor Hypoxia: Molecular Studies and Clinical Exploitation | 1 | 2017 |
| P01CA168585 | Overcoming BRAF-inhibitor Resistance in Melanoma | 1 | 2017 |
| P01HL089707 | Transcriptional Networks During Cardiac Differentiation | 1 | 2017 |
| P01HL107153 | Glycoconjugates and Cardiovascular Disease | 1 | 2017 |
| P41GM103314 | National Resource for Mass Spectrom of Biological Macromolecules | 1 | 2017 |
| P41GM103403 | NE-CAT Center for Advanced Macromolecular Crystallography | 1 | 2017 |
| P50DC012283 | Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Ind* | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/grants?page=33